Trial Profile

Effects of Atorvastatin on Endothelial Function, Vascular and Myocardial Redox State in High Cardiovascular Risk Patients.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Atorvastatin (Primary)
Indications Atherosclerosis; Cardiovascular disorders; Coronary artery disease; Heart failure; Ischaemic heart disorders
Focus Biomarker; Pharmacodynamics

16 Nov 2011 Results assessing vascular redox state and nitric oxide bioavailability presented at the 84th Annual Scientific Sessions of the American Heart Association.
31 Aug 2011 Results assessing the effect of treatment on vascular nitric oxide bioavailability presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
31 Aug 2011 Results assessing the effects of treatment on myocardial redox parameters presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com